Sat.Jan 28, 2023 - Fri.Feb 03, 2023

article thumbnail

Opinion: Disruptive science is leaping forward, not limping along

STAT

A recent study and accompanying news story in the preeminent journal Nature provocatively concludes that disruptive innovation in science has dramatically and mysteriously declined 90% since 1945. The study has prompted a wave of news coverage and tweets decrying the apparent languishing of modern science. We feel that the authors make interesting observations on publishing trends, but their conclusions seem to be quite disconnected from the valuable and transformative innovations that benefit h

364
364
article thumbnail

This biotech CEO secured two billion-dollar Big Pharma deals during the pandemic

PharmaVoice

With the industry focused on cancer and COVID-19, Marc de Garidel made deals centered on cardio.

290
290
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Vital NICE nod for Jazz’s Epidyolex

Pharma Times

UK-wide therapy for patients who have seizures linked to tuberous sclerosis complex

146
146
article thumbnail

Halting Europe’s essential medicines manufacturing exodus

European Pharmaceutical Review

While maintaining a healthy manufacturing industry for production of ‘high tech’ pharmaceuticals, Europe has stepped away from manufacturing essential medicines and active pharmaceutical ingredients (APIs) due to unrelenting price pressures and is now heavily reliant on the import of these critical ingredients. There is now a large regional concentration in the production of generic APIs in Asia with 66 percent of the world’s API production by volume manufactured in India and China. 1 Europe is

article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

STAT+: Medicare Advantage insurers to repay billions under final federal audit rule

STAT

The federal government will audit Medicare Advantage insurers aggressively under a rule finalized Monday, which is expected to result in billions of dollars in overpayments going back toward Medicare’s trust fund and patients over the next decade. However, federal officials watered down one of the auditing policies by giving insurers seven years of immunity from having the samples of their diagnosis coding errors extrapolated to their broader Medicare Advantage membership.

article thumbnail

Boost returns from social strategies with new channels and tactics

PharmaVoice

Emerging channels offer new ways to reach key targets and improve campaign ROI.

246
246

More Trending

article thumbnail

uniQure signs license deal for Apic Bio’s gene therapy for SOD1-ALS

Pharmaceutical Technology

Gene therapy company uniQure has entered into a global licensing agreement with Apic Bio for APB-102 to treat patients with amyotrophic lateral sclerosis (ALS) caused by mutations in superoxide dismutase 1 (SOD1). Under the terms of the deal, uniQure will obtain the worldwide rights to develop and market the clinical stage gene therapy, APB-102. uniQure stated that the license of APB-102 further strengthens its gene therapies pipeline developed for the treatment of neurological disorders as well

article thumbnail

Survey: A majority of Americans support banning all tobacco products

STAT

WASHINGTON — A majority of Americans support banning all tobacco products, according to a new poll published by researchers at the Centers for Disease Control and Prevention. The survey , which was published Thursday in the peer-reviewed journal Preventing Chronic Disease, asked 6,455 people nationwide: “To what extent would you support a policy to prohibit the sale of all tobacco products?

328
328
article thumbnail

Lessons from GoodRx’s “Guide to Successful Copay Programs”

PharmaVoice

Download the complimentary Guide to Successful Copay Programs that delivers actionable insights to pharma leaders.

246
246
article thumbnail

BaseCure collaborates with Aptamer Group to boost gene therapies

Pharma Times

Binders will establish cell types and delivery vehicles may increase uptake of the siRNA therapy

146
146
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

US FDA approves GSK’s Jesduvroq to treat anaemia of CKD

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has approved GlaxoSmithKline ’s (GSK) Jesduvroq (daprodustat) to treat anaemia caused by chronic kidney disease (CKD) in adults who have been on dialysis for at least four months. Jesduvroq is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI). It is claimed to be the only HIF-PHI approved in the country that offers a new oral treatment option for adult patients on dialysis with anaemia of CKD.

105
105
article thumbnail

MRI scans reveal disparate impact of poverty and other ‘toxic stress’ on brains of Black children

STAT

Stressful experiences during early childhood — particularly economic strife — appear to act as a toxic stressor that can alter regions of the brain tied to the processing of stress and trauma, according to a new study published Wednesday. The researchers found that Black children were impacted more than white children, largely because of the higher amounts of poverty and adversity they face.

312
312
article thumbnail

Patients are using social media — clinical trial experts can learn from that

PharmaVoice

Why an alliance of industry leaders is exploring the potential of social media as a treasure trove of real-world patient experience insights.

246
246
article thumbnail

Bill & Melinda Gates Foundation funding for MIP Discovery

Pharma Times

Boost concerns rapid deployment of novel detection reagents for testing in low to middle-income countries

145
145
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Clinical Trials Information System mandatory in EU

European Pharmaceutical Review

From 31 January 2023, all initial clinical trial applications in the European Union (EU) must be submitted via the Clinical Trials Information System (CTIS). According to the European Medicines Agency (EMA), CTIS is now the single-entry point for sponsors and regulators of clinical trials for the submission and assessment of clinical trial data. This follows a one-year transition, during which sponsors could choose whether to apply for a new clinical trial in the EU/EEA in line with the Clinical

article thumbnail

STAT+: Biden administration floats major 2024 pay cut for Medicare Advantage plans

STAT

Medicare Advantage insurers could face an average 2.3% cut to baseline payments in 2024, the Biden administration said Wednesday. If the proposal stands, it would be a net cut of more than $3 billion to the industry. The major reason behind the proposed pay cut: Medicare officials want to update data and coding systems that are used to explain the health conditions of an insurance company’s enrollees.

308
308
article thumbnail

Antitrust watchdogs have pharma in their sights, and the landscape is getting thornier

PharmaVoice

The FTC and DOJ are heightening antitrust enforcement, and pharma deals are a prime target.

240
240
article thumbnail

Green light for AbbVie’s Crohn’s disease therapy Rinvoq

Pharma Times

MHRA approval for Rinvoq which treats adults with moderate to severely active Crohn's Disease

141
141
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Pfizer reports 30% operational growth in full-year 2022 revenues

Pharmaceutical Technology

Pfizer has reported a 30% operational growth in revenues to $100.3bn in full-year 2022 compared with $81.2bn reported last year. The revenues grew 2% operationally excluding Paxlovid and Comirnaty’s contributions. In the fourth quarter (Q4) of 2022, they increased 13% operationally to $24.3bn compared to $23.8bn in the same quarter last year. On an operational basis, the revenues rose by 5%, omitting contributions from Paxlovid and Comirnaty.

104
104
article thumbnail

Opinion: Promises — and pitfalls — of ChatGPT-assisted medicine

STAT

Not long after the artificial intelligence company OpenAI released its ChatGPT chatbot, the application went viral. Five days after its release, it had garnered 1 million users. Since then, it has been called world-changing , a tipping point for artificial intelligence, and the beginning of a new technological revolution. Like others, we began exploring potential medical applications for ChatGPT, which was trained on more than 570 gigabytes of online textual data, extracted from sources like boo

308
308
article thumbnail

Execs at Pfizer, Novartis, Amgen and GSK tackle shifting priorities — reflecting the state of Big Pharma

PharmaVoice

A menagerie of earnings calls this week showed where the Big Pharma players stand in 2023.

147
147
article thumbnail

Milestone product launch for Kelso Pharma

Pharma Times

Acepiro tablets for respiratory diseases will be available across the UK prescription market

137
137
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Minnesota lawmakers are letting PBMs off the hook, and threatening patients’ access to medicines

PhRMA

Middlemen don’t want patients to know how they are stacking the deck against them.

104
104
article thumbnail

STAT+: Teva quits brand lobby PhRMA, in line to lead generic lobby AAM

STAT

WASHINGTON  — Teva Pharmaceuticals has quit the Pharmaceutical Research and Manufacturers of America, STAT has learned.   “ Teva has decided not to renew its membership with PhRMA in 2023,” PhRMA spokesperson Brian Newell confirmed.

297
297
article thumbnail

Weight loss drugs: the promise and pitfalls

PharmaVoice

GLP-1 agonists are dominating the anti-obesity scene — but hurdles remain to their uptake.

147
147
article thumbnail

Medicines policy may be halting Government’s drive for growth

Pharma Times

Lilly is calling for Government to freeze the statutory scheme repayment rate for 2023

133
133
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

What happened to all the antibiotics?

pharmaphorum

Across the world, there are reports of shortages of common antibiotics. Ben Hargreaves examines why these shortages are happening and what is being done in the background to return supply to normal. In many countries across the world, there are shortages of common antibiotics. The problems have been reported across many countries in Europe, in the US, Canada, and Australia.

article thumbnail

STAT+: FDA may not always require post-approval trials to be enrolled before accelerated approvals

STAT

WASHINGTON — A Food and Drug Administration official on Monday gave more clues for how the agency plans to wield new authority to make drug companies enroll post-market clinical trials before granting speedy drug approvals.  That new power is part of reforms to the FDA’s accelerated approval path that Congress recently passed. Accelerated approvals allow the agency to provide fast access to drugs for serious and life-threatening diseases by approving them based on test results

296
296
article thumbnail

Astria Therapeutics’ edge in an ultra-rare disease

PharmaVoice

With positive early phase data, CEO Jill Milne is aiming to bring an improved preventative option to patients with hereditary angioedema.

130
130
article thumbnail

Cambridge Cognition and Aardex collaborate to boost decentralised clinical trials

Pharma Times

Partnership involves the study of real-time patient data and identification of adherence issues

130
130
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.